Table 1 Univariate and multivariate survival analyses in TNBC patients (n=56)
Items | Contents | HR | 95% CI | P- value |
|---|---|---|---|---|
Univariate survival analysis | ||||
Age | <60 years | 1 | ||
60–69 years | 2.17 | 0.61, 7.70 | 0.23 | |
⩾70 years | 2.41 | 0.60, 9.73 | 0.218 | |
Total | 0.157 | |||
Basal | Non-basal | 1 | — | |
Basal | 5.92 | 0.77, 45.63 | 0.088 | |
Total | — | |||
Stage | I or II | 1 | — | |
III | 3.66 | 0.94, 14.17 | 0.061 | |
IV | 10.09 | 2.55, 39.93 | 0.001 | |
Total | <0.001 | |||
ALDH1 | (−) | 1 | — | |
(1+) | 2.02 | 0.37, 11.02 | 0.418 | |
(2+) | 3.6 | 0.51, 25.64 | 0.201 | |
(3+) | 2.08 | 0.35, 12.45 | 0.423 | |
Total | 0.386 | |||
ERO1-α | (−) or (1+) | 1 | — | |
(2+) | 4.95 | 0.91, 27.06 | 0.065 | |
(3+) | 5.99 | 1.09, 32.76 | 0.039 | |
Total | 0.029 | |||
Multivariate survival analysis | ||||
Stage | I or II | 1 | ||
III | 1.79 | 0.35, 9.26 | 0.489 | |
IV | 14.92 | 2.20, 101.09 | 0.006 | |
Total | 0.011 | |||
ERO1-α | (−) or (1+) | 1 | — | |
(2+) | 6.69 | 1.01, 44.15 | 0.048 | |
(3+) | 5.99 | 1.05, 36.23 | 0.044 | |
Total | 0.041 | |||
